The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for DE Walters


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.EBI
Depaul University
Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors.EBI
University of Illinois At Chicago
Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation.EBI
Purdue University
Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation.EBI
Purdue University
Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands.EBI
Purdue University
Keto-imidazopyridine derivatives as RORc modulatorsBDB
Genentech
2-(morpholin-4-yl)-1,7-naphthyridinesBDB
Bayer Pharma Aktiengesellschaft
Amide compounds, compositions and applications thereofBDB
Advinus Therapeutics
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.BDB
Novartis Pharmaceuticals
2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors.BDB
Merck Sharp and Dohme Research Laboratories
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor.BDB
Parke-Davis Pharmaceutical Research